Takuro Goto Selected Research

Takuro Goto Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 12/2018
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2018
4	Carcinogenesis 01/2023 - 01/2020
3	Disease Progression 01/2024 - 08/2019
3	Virus Diseases (Viral Diseases) 01/2024 - 01/2020
3	Testicular Neoplasms (Testicular Cancer) 07/2023 - 01/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 12/2017
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2020 - 01/2019
2	Lymphatic Metastasis 08/2019 - 01/2015
2	Ischemia 01/2019 - 01/2019
1	Ganglion Cysts (Ganglion) 11/2023
1	Erectile Dysfunction 11/2023
1	Teratoma (Teratoid Tumor) 07/2023
1	Colorectal Neoplasms (Colorectal Cancer) 06/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2023
1	Dental Caries (Decay, Dental) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Margins of Excision 01/2022
1	Neoplasm Metastasis (Metastasis) 08/2019
1	Extranodal Extension 08/2019
1	Hyperplasia 01/2019
1	Atherosclerosis 01/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018

Drug/Important Bio-Agent (IBA)

7	Androgen Receptors (Androgen Receptor)IBA 01/2024 - 12/2018
6	Small Interfering RNA (siRNA)IBA 01/2024 - 12/2018
4	AndrogensIBA 01/2024 - 12/2017
4	CarcinogensIBA 01/2023 - 01/2020
4	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 01/2020
3	LigandsIBA 01/2024 - 01/2020
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 12/2017
3	Estrogen ReceptorsIBA 01/2021 - 01/2020
2	esaxerenoneIBA 01/2024 - 01/2023
2	Eplerenone (Inspra)FDA LinkGeneric 01/2024 - 01/2023
2	AldosteroneIBA 01/2024 - 01/2023
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2024 - 01/2023
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2024 - 01/2023
2	AntibodiesIBA 06/2023 - 01/2019
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 02/2021
2	Dihydrotestosterone (Androstanolone)IBA 01/2020 - 12/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2018
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2020
1	MineralocorticoidsIBA 01/2024
1	Alprostadil (Muse)FDA LinkGeneric 11/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 07/2023
1	Fetal Proteins (Fetoprotein)IBA 07/2023
1	Vitamin D FDA LinkGeneric 06/2023
1	ChromatinIBA 06/2023
1	MethylcholanthreneIBA 01/2023
1	CotinineIBA 01/2023
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2023
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Gemcitabine FDA Link 01/2020
1	Flutamide (Eulexin)FDA LinkGeneric 01/2020
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	ButylhydroxybutylnitrosamineIBA 01/2020
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2020
1	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 01/2020
1	silodosin FDA Link 01/2020
1	naftopidilIBA 01/2020
1	hydroxyflutamideIBA 01/2020
1	1-methyladenosineIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Phosphodiesterase 5 InhibitorsIBA 01/2019
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	CreatinineIBA 01/2018
1	Cystatin CIBA 01/2018

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 09/2021 - 01/2020
3	Neoadjuvant Therapy 09/2021 - 01/2020
2	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 01/2022
2	Therapeutics 01/2021 - 12/2017
1	Intravenous Administration 11/2023
1	Intravenous Infusions 11/2023
1	Lymph Node Excision (Lymph Node Dissection) 07/2023
1	Radiotherapy 06/2023
1	Aftercare (After-Treatment) 01/2021
1	Chemoprevention 01/2020
1	Cystectomy 08/2019
1	Castration 12/2017
1	Orchiectomy (Orchidectomy) 01/2015